z-logo
open-access-imgOpen Access
Creation of a pharmacogenomics patient portal complementary to an existing institutional provider-facing clinical decision support system
Author(s) -
Elizabeth Lipschultz,
Keith Danahey,
Tien M. Truong,
Emily Schierer,
Samuel L. Volchenboum,
Mark J. Ratain,
Peter H. O’Donnell
Publication year - 2021
Publication title -
jamia open
Language(s) - English
Resource type - Journals
ISSN - 2574-2531
DOI - 10.1093/jamiaopen/ooab067
Subject(s) - patient portal , clinical decision support system , pharmacogenomics , decision support system , medicine , relevance (law) , personalized medicine , knowledge management , computer science , health care , bioinformatics , artificial intelligence , economics , pharmacology , economic growth , political science , law , biology
Background Applied pharmacogenomics presents opportunities for improving patient care through precision medicine, particularly when paired with appropriate clinical decision support (CDS). However, a lack of patient resources for understanding pharmacogenomic test results may hinder shared decision-making and patient confidence in treatment. We sought to create a patient pharmacogenomics education and results delivery platform complementary to a CDS system to facilitate further research on the relevance of patient education to pharmacogenomics. Methods We conceptualized a model that extended the data access layer of an existing institutional CDS tool to allow for the pairing of decision supports offered to providers with patient-oriented summaries at the same level of phenotypic specificity. We built a two-part system consisting of a secure portal for patient use and an administrative dashboard for patient summary creation. The system was built in an ASP.NET and AngularJS architecture, and all data was housed in a HIPAA-compliant data center, with PHI secure in transit and at rest. Results The YourPGx Patient Portal was deployed on the institutional network in June 2019. Fifty-eight unique patient portal summaries have been written so far, which can provide over 4500 results modules to the pilot population of 544 patients. Patient behavior on the portal is being logged for further research. Conclusions To our knowledge, this is the first automated system designed and deployed to provide detailed, personalized patient pharmacogenomics education complementary to a clinical decision support system. Future work will expand upon this system to allow for telemedicine and patient notification of new or updated results.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom